Current advances in the treatment of myofascial pain syndrome with trigger point injections: A review.

Medicine 2024 Vol.103(40) p. e39885

Anwar N, Wei X, Jie Y, Hongbo Z, Jin H, Zhu Z

관련 도메인

Abstract

Myofascial pain syndrome (MPS) caused by trigger points in muscles is a common cause of local or generalized pain, which is clinically common, has a high incidence, and has no specific cure. The most popular and widely used clinical method mainly targets the trigger point for treatment, i.e. trigger point injection (TPI) therapy. The injectable drugs mainly include glucose, saline, local anesthetics, botulinum toxin type A, platelet-rich plasma, platelet-poor plasma, steroid preparations, etc. This method is low cost and less invasive, and early clinical applications have shown good efficacy. In this paper, we have reviewed clinical research progress in treating MPS with TPI therapy.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 1
해부 myofascial scispacy 1
해부 muscles scispacy 1
해부 platelet-rich plasma scispacy 1
해부 platelet-poor plasma scispacy 1
약물 glucose C0017725
glucose
scispacy 1
약물 platelet-rich C0370220
Platelet rich plasma
scispacy 1
약물 steroid C0038317
Steroids
scispacy 1
약물 TPI → trigger point injection scispacy 1
약물 saline scispacy 1
질환 myofascial pain C0553642
Soft tissue rheumatism
scispacy 1
질환 MPS → Myofascial pain syndrome C0016053
Fibromyalgia
scispacy 1
질환 pain C0030193
Pain
scispacy 1
기타 botulinum toxin type A scispacy 1

MeSH Terms

Humans; Myofascial Pain Syndromes; Trigger Points; Anesthetics, Local; Botulinum Toxins, Type A; Platelet-Rich Plasma; Injections, Intramuscular

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문